Emerging and Alternative Therapies For Parkinson Disease: An Updated Review.

帕金森病 医学 疾病 重症监护医学 临床试验 神经保护 生物信息学 梅德林 神经科学 评论文章 多巴胺能
作者
Atul Kabra,Rohit Sharma,Ruchika Kabra,Uttam Singh Baghel
出处
期刊:Current Pharmaceutical Design [Bentham Science]
卷期号:24 (22): 2573-2582 被引量:15
标识
DOI:10.2174/1381612824666180820150150
摘要

Parkinson's disease (PD) is standout amongst the most common neurodegenerative malady with unpredictable dynamic pathology. At present, accessible traditional choices for PD have certain impediments of their own, and subsequently persistent consistence and fulfillment are low. Current contemporary treatment options just give symptomatic alleviation constrained control to anticipate malady progression, bringing about poor patient consistence and fulfilment. Numerous rising pharmacotherapies for PD are in various phases of medical improvement. Treatments incorporate adenosine A2A receptor antagonists, anti-apoptotic agents, monoamine oxidase inhibitors, glutamate receptor antagonists, and antioxidants for example, N-acetyl cysteine, edaravone, and coenzyme Q10. Other rising nonpharmacotherapies incorporate microRNAs, viral vector gene therapy, stem cells transglutaminases, RTP801, and glial derived neurotrophic factor (GDNF). Furthermore, surgeries including profound pallidotomy, deep brain stimulation, thalamotomy and gamma knife surgery have developed as elective mediations for cutting edge PD patients who have totally used common medications and still suffer from unrelenting motor symptoms. Complementary and Alternative medicine (CAM) modalities, such as Yoga, acupuncture, Tai Chi, Music therapies are highly practiced in several countries, offer some of the safer and effective treatment modalities for PD. While a few of these treatments hold much assurance in postponing the beginning of ailment and moderating its progression, more pharmacotherapies and careful mediations should be examined in various phases of PD. Therefore, the main objective of our review is to fill the gap between the researches and provide updated and productive information about the research reported in the last couple of years and can fulfil the most reassuring plausibility for encourage treatment of Parkinson Disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
建议保存本图,每天支付宝扫一扫(相册选取)领红包
实时播报
Jasper应助忧虑的代容采纳,获得10
1秒前
乐乐应助jialin采纳,获得10
6秒前
科研通AI2S应助lifeup采纳,获得10
6秒前
8秒前
suk发布了新的文献求助10
11秒前
12秒前
匆匆完成签到 ,获得积分10
12秒前
fyy完成签到,获得积分10
13秒前
13秒前
CANDY完成签到,获得积分20
15秒前
15秒前
suk完成签到,获得积分10
17秒前
jialin发布了新的文献求助10
19秒前
20秒前
Akim应助科研通管家采纳,获得30
20秒前
共享精神应助科研通管家采纳,获得10
20秒前
CodeCraft应助科研通管家采纳,获得10
20秒前
21秒前
21秒前
探索发布了新的文献求助10
21秒前
fyy发布了新的文献求助10
25秒前
Cain发布了新的文献求助30
25秒前
开小差发布了新的文献求助10
27秒前
jialin完成签到,获得积分10
28秒前
自然的铃铛完成签到,获得积分20
29秒前
29秒前
谷雨下完成签到,获得积分10
29秒前
cyh完成签到 ,获得积分10
30秒前
cctv18应助自然的铃铛采纳,获得10
34秒前
36秒前
37秒前
Akim应助脆桃采纳,获得10
39秒前
666完成签到 ,获得积分10
42秒前
45秒前
科研通AI2S应助lifeup采纳,获得10
50秒前
Kenny-Liliy完成签到 ,获得积分0
50秒前
酷波er应助那小子好白采纳,获得10
52秒前
53秒前
wali完成签到 ,获得积分0
53秒前
刘卫朋完成签到,获得积分10
57秒前
高分求助中
Bioinspired Catalysis with Biomimetic Clusters 1000
Work hardening in tension and fatigue : proceedings of a symposium, Cincinnati, Ohio, November 11, 1975 1000
Teaching Social and Emotional Learning in Physical Education 900
The Instrument Operations and Calibration System for TerraSAR-X 800
Lexique et typologie des poteries: pour la normalisation de la description des poteries (Full Book) 400
Sustainable Land Management: Strategies to Cope with the Marginalisation of Agriculture 400
Transformerboard III 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2350948
求助须知:如何正确求助?哪些是违规求助? 2057001
关于积分的说明 5124495
捐赠科研通 1787505
什么是DOI,文献DOI怎么找? 892890
版权声明 557070
科研通“疑难数据库(出版商)”最低求助积分说明 476311